- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris
The unique partnership will bring Peloton's world-class fitness and wellness content to Twin's AI digital twin program, proven to treat
A retrospective cohort study of claims data demonstrated that following hospital discharge, patients adherent to YUPELRI experienced significantly fewer, and
Next-Generation solution supports the NHS 10-year Health Plan and the mission to create a workforce that is fit for the
Next-Generation solution supports the NHS 10-year Health Plan and the mission to create a workforce that is fit for the
Moreover, just 14.1 per cent of the allocated ₹65,700 crore ($7.5 billion) in subsidies have been released till July 2025.